Skip to main content
Caplight Logo









Selta Square

Selta Square

Private
South KoreaHealthcare & Life Scienceshttps://seltaglobal.com/

Last Round

Series A

Jan 27, 2025

Total Funding Raised

$6.8M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Selta Square is a healthcare technology company that provides AI-powered pharmacovigilance and drug safety monitoring solutions for the pharmaceutical industry.

Sector

Healthcare & Life Sciences

Verticals

Compliance & Risk, Medical AI, RegTech, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

pharmacovigilancePVdrug safety monitoringregulatory complianceMedDRA codingRegTechadverse event reportingAI automationhealth-techsafety databasepharmaceutical softwarePVaaSbusiness process servicesBPSAI hallucination

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Selta Square Comparables

Compare Selta Square with similar companies based on industry and business-model similarity.

Selta Square comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Datafoundry
85%
DrugCard
85%
PubHive Ltd.
83%

Selta Square Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 27, 2025
AcceleratorMay 19, 2023

Key People

Founding team and executive leadership

Minkyung Jessica Shin

CEO

Executive Team

Selta Square Investors

Notable investors and investment history

Selta Square investors
InvestorRounds
Korea Investment PartnersSeries A
KB InvestmentSeries A
Yuanta InvestmentSeries A
SJ Investment PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 21% QoQ, from 29 to 35 employees.

  • May 24, 2026

    Grew 16% QoQ, from 25 to 29 employees.

Selta Square Filings

Explore SEC and related filing metadata, where available.

Selta Square filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Selta Square's valuation, stock price, and market status.

Is Selta Square a public or private company?

Selta Square is a private company.

What is the current stock price of Selta Square?

Selta Square is a private company with no public stock price. No recent secondary market data is available.

How much is Selta Square worth (valuation)?

Valuation information for Selta Square is not publicly available.

Can I buy Selta Square stock?

Selta Square shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Selta Square's last funding round?

Selta Square's most recent funding round was Series A on January 27, 2025.

Who are the main investors in Selta Square?

Key investors in Selta Square include Korea Investment Partners, KB Investment, Yuanta Investment, SJ Investment Partners.

Will Selta Square IPO soon?

No public IPO plans have been announced for Selta Square.

How can I track Selta Square secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Selta Square's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Employee Range17
Year Founded2021
Last FundingJan 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?